The money (no numbers have been mentioned) will be used to further develop Bigfoot’s automated insulin delivery service called smartloop. The cloud-connected diabetes management system works with wearable insulin delivery and glucose monitoring tools, accessed through a companion app, and all delivered through a monthly bundled subscription service. Bigfoot completed its first clinical trial in late 2016 and expects to begin another this year.